PE-conjugated Anti-IL13(lebrikizumab biosimilar) mAb

Price: 100 test ￥1360.00

SKU: BME100548P Category: Biosimilar reference antibodies

Uniprot ID	P35225
Common Name	DRM 06;DRM-06;DRM06;DRM 6;DRM-6;DRM6;LY 3650150;LY-3650150;LY3650150;MILR1444A;MILR-1444A;MILR 1444;ARG 3637;ARG-3637;ARG3637;RO 5490255;RO-5490255;RO5490255;TNX 650;TNX-650;TXN650
Synonyms	P600;IL-13;NC30
Applications	Flow Cyt
Recommended Dilutions	Flow Cyt 1:100
Formulation & Reconstitution	Liquid，PBS with 0.05% Proclin300, 1% BSA
Host Species	N/A
IgG type	IgG4
Reactivity	Human
Target	IL13
Description	PE-conjugated Anti-IL13(lebrikizumab biosimilar) mAb
Delivery	6-8 weeks
Storage & Shipping	Store at 2°C-8°C for 6 months
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Usage	Research use only
Conjugate	PE-conjugated
DIMA Disclaimer	All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement.